The thyrotropin receptor in thyroid carcinoma
Hovens, G.C.J.
Citation
Hovens, G. C. J. (2008, September 18). The thyrotropin receptor in thyroid carcinoma.
Retrieved from https://hdl.handle.net/1887/13103
Version: Corrected Publisher’s Version
License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden
Downloaded from: https://hdl.handle.net/1887/13103
Note: To cite this publication please use the final published version (if applicable).
The Thyrotropin Receptor In Thyroid Carcinoma
Guido C.J. Hovens
The Thyrotropin Receptor In Thyroid Carcinoma Dit onderzoek is financieel ondersteund door KWF KANKER BESTRIJDING
(UL 2001 -2568)
©2008 Guido C.J. Hovens Print: Ponsen & Looijen BV
De druk van dit proefschri werd financieel ondersteund door KWF KANKER
BESTRIJDING, Ipsen, J.E. Jurriaanse Schng, Pfizer en Novars Oncology
ISBN 978-90-6464-280-7
The Thyrotropin Receptor In Thyroid Carcinoma
Proefschri
ter verkrijging van
de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof.mr.dr. P. F. van der Heijden,
volgens besluit van het College voor Promoes te verdedigen op donderdag 18 september 2008
klokke 13.45 uur
door
Guido Chrisaan Johannes Hovens
geboren te Tegelen In 1976.
Promoecommissie
Promotores:
Copromotor:
Referent:
Overige leden:
Prof.dr. J.W.A. Smit Prof.dr. J.A. Romijn Dr. H.B.J. Karperien
Dr. T.P.Links (Universitair Medisch Centrum Groningen) Prof.dr. J. Morreau
Prof.dr. C.W.G.M. Lowik Prof.dr. J. Kievit Prof.dr. H. Pijl
Ignoran quem portum petat nullus suus ventus est
If one does not know to which port one is sailing, no wind is favorable.
Lucius Annaeus Seneca (4BC - AD65)
General Introducon
Associaons of Serum Thyrotropin Concentraons with Recurrence and Death in Differenated Thyroid Cancer Treatment of the follicular thyroid carcinoma cell-line FTC-133 with Troglitazone and Lovastan synergiscally in- creases expression of G1 transion inhibitors and induces re-differenaon
Superior Thyrotropin Receptor Binding and Acvaon of a Novel, Modified, Single Chain Thyroid Smulang Hormone A Bio-Luminescence Assay for Thyrotropin Receptor
Anbodies Predicts Serum Thyroid Hormone Levels in Paents with de novo Graves’ Disease
Inducon of Smulang Thyrotropin Receptor Anbodies aer Radioiodine Therapy for Toxic Mulnodular Goiter and Graves Disease Measured with a Novel Bio-assay.
Summary and Discussion Samenvang en Discussie References
Nawoord Curriculum Vitae List of Publicaons
9 27
41
53
69
81
91 105 121 147 151 155 Chapter 1
Chapter 2
Chapter 3
Chapter 4
Chapter 5
Chapter 6
Chapter 7 Chapter 8
